|
Volumn 2, Issue 1, 2002, Pages 20-26
|
Chemotherapy in epithelial ovarian cancer.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARCINOMA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
FEMALE;
HUMAN;
METASTASIS;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
OVARY TUMOR;
PATHOLOGY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
TUMOR RECURRENCE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
OVARIAN NEOPLASMS;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 0036463902
PISSN: 15345874
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (8)
|
References (34)
|